Labiotech.eu

News and Trends 18 Jun 2020

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic its Covid-19 vaccine candidate and cancer immunotherapies made from messenger RNA. The company’s five existing investors contributed to the round, including Dutch VC firm LSP, and the Boehringer Ingelheim Venture Fund, based in Germany. Four new investors also contributed — […]

June 18, 2020 - 3 minutesmins - By Helen Albert

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

A Series A round closed by Barcelona-based startup Ona Therapeutics will finance the preclinical development of a drug that prevents cancer from spreading in the body by targeting the metabolism of cancer cells. The round was supported by returning investor Asabys Partners, as well as new European investors including Alta Life Sciences, Bpifrance, Fund+, and […]

June 17, 2020 - 2 minutesmins - By Victor Kotsev

universal cancer vaccine mrna biontech personalized medicine

News and Trends 17 Jun 2020

German Government Invests €300M in mRNA Biotech CureVac

The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is developing a vaccine for Covid-19 using messenger RNA technology. The unusually large investment will be made through the state-owned bank Kreditanstalt für Wiederaufbau, which will gain a 23% stake in the company. “CureVac retains complete operational and strategic independence,” Franz-Werner […]

June 17, 2020 - 4 minutesmins - By Helen Albert

In Depth 17 Jun 2020

How is European Biotech Rising to the Covid-19 Testing Challenge?

Diagnostics have been thrown into the spotlight in the Covid-19 pandemic because of their instrumental role in preventing further infections. However, developing a test for Covid-19 isn’t an easy task. What exactly is needed to make a good Covid-19 test, and how are European biotech companies working to fill this need? While the development of […]

June 17, 2020 - 10 minutesmins - By Mark Livingstone

News and Trends 16 Jun 2020

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the manufacturing efficiency of human cells for use in cell therapy and drug discovery. The impressive deal brings Bit Bio’s total funding to €44.4M since it was spun off from the University of Cambridge in 2016. It’s the second-largest Series A […]

June 16, 2020 - 3 minutesmins - By External Contributor

News and Trends 15 Jun 2020

Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative

The startup Protera is moving from Santiago de Chile to Paris following a €5M Series A round that will let the company scale up the production of an antifungal protein food preservative to the pilot scale. The Series A round was led by the European venture capital firm Sofinnova Partners, and will allow the company […]

June 15, 2020 - 4 minutesmins - By David Kirk

News and Trends 15 Jun 2020

Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech

The Novo Nordisk Foundation has awarded a five-year grant of €100M to the DTU Biosustain research center near Copenhagen to support the development of sustainable green technology. DTU Biosustain was founded in 2011 and forms part of the Danish Technical University. The Novo Nordisk Foundation, which is one of the largest charitable foundations in the […]

June 15, 2020 - 3 minutesmins - By Helen Albert

In Depth 15 Jun 2020

Drug Development in Covid-19 Times: Is Going Remote the Answer?

With the coronavirus pandemic forcing scientific research labs to close around the globe, it seems almost inevitable that the ongoing crisis will accelerate the growing demand for remote drug development. A number of European companies see this as an opportunity to introduce computer-aided biology and robot-driven labs. In recent years, the pharmaceutical industry has been […]

June 15, 2020 - 7 minutesmins - By David Cox

News and Trends 11 Jun 2020

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest strategic alliance in European biotech in 2020. The partners aim to commercialize three phase I-stage antibody drugs for undisclosed types of solid and liquid cancer. Upfront, the US AbbVie will pay the Danish biotech €659M, with up to €2.77B available […]

June 11, 2020 - 3 minutesmins - By External Contributor

News and Trends 11 Jun 2020

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US big pharma Eli Lilly to develop RNA drugs that are delivered in exosomes to the brain to treat neurological diseases. As part of the deal, Evox will get €17.6M upfront to fund research for the next three years and Lilly […]

June 11, 2020 - 3 minutesmins - By Helen Albert

In Depth 11 Jun 2020

How the Biotech Industry Makes Flavors Healthy and Eco-Friendly

The food industry is under pressure to create products that don’t just taste great, but that are also good for our health and for the environment. Biotechnology is emerging as a solution to enjoy the flavors we love without damaging our bodies or nature. We’ve been adding flavor to our food since ancient times. Throughout […]

June 11, 2020 - 9 minutesmins - By Clara Rodríguez Fernández

equine encephalitis mosquito bavarian nordic vaccine

News and Trends 9 Jun 2020

Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I

With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step closer to commercializing the first vaccine to protect humans against equine encephalitis, a mosquito-borne infection that has been explored for use as a bioweapon. The trial was fully funded by the US Department of Defense. The vaccine was well-tolerated and […]

June 9, 2020 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

German Government Invests €300M in mRNA Biotech CureVac

How is European Biotech Rising to the Covid-19 Testing Challenge?

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative

Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech

Drug Development in Covid-19 Times: Is Going Remote the Answer?

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

How the Biotech Industry Makes Flavors Healthy and Eco-Friendly

Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!